This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lucero, N. E.
Right arrow Articles by Bolpe, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lucero, N. E.
Right arrow Articles by Bolpe, J. E.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, May 1998, p. 1425-1427, Vol. 36, No. 5
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Buffered Plate Antigen Test as a Screening Test for Diagnosis of Human Brucellosis

Nidia E. Lucero1,* and Jorge E. Bolpe2

Instituto Nacional de Microbiología "Dr. C. G. Malbrán,"1 and Departamento de Zoonosis Rurales, España 770, 7300 Azul,2 Buenos Aires, Argentina

Received 27 May 1997/Returned for modification 12 July 1997/Accepted 31 January 1998

Brucellosis in Argentina is currently investigated in bank donor blood by the standard plate agglutination test (PAT). This study evaluated the buffered plate antigen test (BPA), now used to screen for bovine brucellosis, as a screen for human disease. Of 57 sera from patients with culture-confirmed brucellosis, 100% were detected with the BPA. Of 142 sera positive by rose bengal (RB) and complement fixation (CF), from patients with clinical evidence of brucellosis, the BPA detected 100%. Of 307 sera from a nonsymptomatic population that were RB and CF negative, the BPA detected 99.67% of the negative sera. The data indicate that the BPA is satisfactory compared to the other agglutination tests employed. It is an inexpensive and practical screening test and reduces the nonspecific reactions detected by the PAT.


* Corresponding author. Mailing address: Instituto Nacional de Microbiología "Dr. C. G. Malbrán," Velez Sarsfield 563, 1281 Buenos Aires, Argentina. Phone: 54-1-303-1806/11. Fax: 54-1-303-2382. E-mail: NIDIA{at}IMPSAT1.COM.AR.


Journal of Clinical Microbiology, May 1998, p. 1425-1427, Vol. 36, No. 5
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Jacob, N. R., Rodriguez, C. G., Binaghi, M. A., Scapellato, P. G., Rosales Ostriz, M. B., Ayala, S. M., Lucero, N. E. (2008). Brucellosis complicating chronic non-infectious disorders: diagnostic and therapeutic dilemmas. J Med Microbiol 57: 1161-1166 [Abstract] [Full Text]  
  • Lucero, N. E, Escobar, G. I, Ayala, S. M, Jacob, N. (2005). Diagnosis of human brucellosis caused by Brucella canis. J Med Microbiol 54: 457-461 [Abstract] [Full Text]  
  • Lucero, N. E, Jacob, N. O, Ayala, S. M, Escobar, G. I, Tuccillo, P., Jacques, I. (2005). Unusual clinical presentation of brucellosis caused by Brucella canis. J Med Microbiol 54: 505-508 [Abstract] [Full Text]  
  • Lucero, N. E., Escobar, G. I., Ayala, S. M., Paulo, P. S., Nielsen, K. (2003). Fluorescence polarization assay for diagnosis of human brucellosis. J Med Microbiol 52: 883-887 [Abstract] [Full Text]  
  • LUCERO, N.E., ESCOBAR, G.I., AYALA, S.M., LOPEZ, G. (2002). Sensitivity and specificity of an indirect enzyme-linked immunoassay for the diagnosis of Brucella canis infection in dogs. J Med Microbiol 51: 656-660 [Abstract] [Full Text]  
  • Lucero, N. E., Foglia, L., Ayala, S. M., Gall, D., Nielsen, K. (1999). Competitive Enzyme Immunoassay for Diagnosis of Human Brucellosis. J. Clin. Microbiol. 37: 3245-3248 [Abstract] [Full Text]